About Us

Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 110 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.

Achievements

Recent Placements

Find a Recruiter

0

The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.

Our Team

Solutions And Expertise

Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database.  Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.

Solutions
  • Advisory Services
  • Assessment
  • Board Services
  • Culture Shaping
  • Data Analy./Mrkt. Intell.
  • Diversity & Inclusion
  • Executive Coaching
  • Executive Search
  • Leadership Consulting
  • Leadership Develop.
  • Mgmt. Consulting
  • Onboarding
  • Recruitment Research
  • Succession Planning
Industries
  • Agriculture
  • Biotechnology
  • Chemicals
  • Clean Tech./Sustain.
  • Clinical Research
  • Consulting
  • Consumer
  • Consumer Products
  • Consumer Services
  • Data & Analytics
  • Devices
  • Energy
  • Family Offices
  • Financial Services
  • FinTech
  • Foundations
  • Healthcare Services
  • High Tech
  • Industrial
  • Industrial Products
  • Internet
  • Life Sci./Healthcare
  • Machine Learning
  • Medical
  • Medical Devices
  • Natural Resources
  • Non-Profit
  • Pharmaceuticals
  • Private Equity
  • Professional Services
  • Software
  • Supply Chain
  • Technology
  • Venture Capital
Functions
  • Board/Governance
  • Business Development
  • CEO/President
  • Data/Analytics
  • Diversity & Inclusion
  • Finance/Accounting
  • General Management
  • GM/Operations
  • Human Resources
  • Information/Digital
  • Investor Relations
  • Legal/Compliance
  • Manufacturing
  • Marketing & Sales
  • Medical/Clinical
  • Research & Develop.
  • Supply Chain

News Briefings

Coulter Partners Places Two Leaders for Dalriada

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of two key leaders for Dalriada in Mississauga, Ontario. Adam Davenport joins the small molecule drug discovery company as chief research and development officer, and Frosty Loechel signs on as senior vice president biology, discovery strategy group. Both individuals previously worked for Hamburg, Germany-headquartered life science

Coulter Partners Recruits Chief Development Officer for TargED Biopharmaceuticals

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Gerben van ‘t Klooster as chief development officer for TargED Biopharmaceuticals in London. “We are thrilled to welcome Gerben to our team at TargED Biopharmaceuticals,” said Kristof Vercruysse, CEO of TargED Biopharmaceuticals. “He brings a wealth of experience and expertise that will be invaluable to our

As Investors Retreat, Healthcare/Life Sciences Sector Stays Resilient

Healthcare and life science organizations are facing an increasingly complex landscape, with rapid technological advancements, changing regulatory environments, and heightened public scrutiny. As a result, these companies have been turning to executive search firms more than ever to land world-class leadership. The most pressing challenge has been finding high-impact, innovative leaders who can navigate this

Coulter Partners Recruits Chief Scientific Officer for Sonata Therapeutics

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Francesco Marincola as chief scientific officer of Sonata Therapeutics Inc., a biotechnology company in Boston. “Throughout his successful career across academia and industry over the last few decades, Franco has stood at the forefront of discovery and drug development,” said Volker Herrmann, president and CEO of

Press Releases

Coulter Partners places Board Director at IN8bio

Coulter Partners is pleased to announce the placement of Jeremy Graff, Ph.D. to the Board of Directors of IN8bio, Inc. (Nasdaq: INAB). IN8bio is a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies. Dr. Jeremy Graff spent 17 years at Eli Lilly and Company, where he built and led the translational oncology

Coulter Partners places Vice President of Intellectual Property at Amphista Therapeutics

Coulter Partners recently partnered with Amphista Therapeutics to further strengthen their team in Cambridge with the appointment of Dr Victoria Lovatt as Vice President of Intellectual Property. Amphista Therapeutics is a leader in next generation targeted protein degradation (TPD) approaches and is focused on transforming the lives of patients with severe diseases including cancer. The

Coulter Partners Places Two Industry-Leading Infectious Disease Experts as Board Directors at RQ Bio

Coulter Partners recently partnered with RQ Bio to strengthen the board with the placements of Dr. W. Ripley Ballou, previously Vice President and Head at GSK Global Vaccines and Dr. Jacques Cholat, previously President of Merck Vaccines. The appointments confirm RQ Bio’s ambition to become the world-leading company in passive immunization for infectious diseases. The

Coulter Partners Places Three Board Directors at Our Future Health Trading Ltd

Coulter Partners recently partnered with Our Future Health Trading Ltd, in placing Cristina Ortega Duran, Andy Richards and Simon Sturge as Board Directors. Our Future Health is an ambitious collaboration between the public, charity and private sectors to build the UK’s largest health research program – bringing people together to develop new ways to prevent,

Coulter Partners expands its global team with thirteen further appointments in the UK, France, Italy, and the US

London, 15th November 2022 – Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, announces thirteen key appointments. These new colleagues further strengthen the global team, alongside recently appointed Justine McIlroy, Client Partner, based in London. Victoria Claro, Associate Director Anne-Charlotte Boudet-Morel, Senior Consultant Brett Phillips, Senior Consultant